Hap Trading, LLC Alkermes Plc. Call Options Transaction History

Hap Trading, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q4 2020 Feb 16, 2021	SELL	$15.39 - $22.1 $224,694 - $322,660	-14,600 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$16.16 - $20.66 $3.23 Million - $4.13 Million	-199,900 Reduced 93.19%	14,600 $2,000
Q2 2020 Aug 10, 2020	BUY	$13.31 - $19.41 $2.85 Million - $4.16 Million	214,500 New	214,500 $164,000
Q3 2018 Nov 09, 2018	SELL	$38.6 - $46.12 $3.91 Million - $4.67 Million	-101,200 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$40.56 - $51.36 $4.1 Million - $5.2 Million	101,200 New	101,200 $28,000
Q1 2018 May 11, 2018	SELL	$53.61 - $67.26 $814,872 - $1.02 Million	-15,200 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$47.69 - $55.39 $724,888 - $841,928	15,200	15,200 $93,000

408

177M

229K

436K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.92B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.